Anlon Healthcare IPO GMP History
Anlon Healthcare IPO has been listed on September 3, 2025 at a listing price of ₹92, against the issue price of ₹91 — a gain of ₹1 (+1.1%). The GMP peaked at ₹5 on 25 August 2025 and reached a low of ₹2 on 29 August 2025. The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Anlon Healthcare IPO raised ₹121.03 Cr. through its IPO at a price band of ₹86 to ₹91 per share, with a lot size of 164 shares. The IPO was open for subscription from 26 Aug 2025 to 29 Aug 2025.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
GMP trend
Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 9 Nov, 9:03 PM IST.
Day-wise GMP
The last reading of each day, newest first. Arrows compare with the previous day.
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| 29 Aug 2025 | ₹ 2 | ▼ | 2% | — | — |
| 28 Aug 2025 | ₹ 3 | ▼ | 3% | — | — |
| 26 Aug 2025 | ₹ 4 | ▼ | 4% | — | — |
| 25 Aug 2025 | ₹ 5 | — | 5% | — | — |
Anlon Healthcare IPO dates
Key dates from opening to listing. Today is 10 November.
- Open 26 Aug 2025
- Close 29 Aug 2025
- Allotment 01 Sep 2025
- Refund/credit 02 Sep 2025
- Listing 03 Sep 2025
Anlon Healthcare IPO actual listing price
How the grey market's final call compared with the listing-day open.
| Issue price | ₹91 |
|---|---|
| GMP-based estimate (pre-listing) | ₹93 (+2.2%) |
| Listing gain / loss | +₹1 per share |
| Listing date | 03 Sep, 2025 |
| Actual listing price | ₹92 (+1.1%) |
Is Anlon Healthcare IPO GMP reliable?
Grey market premium for Anlon Healthcare IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- 04Cross-check before acting: Review the Anlon Healthcare IPO full review for a fundamentals-based assessment before making any grey market trades.
Anlon Healthcare IPO Kostak rate explained
Two ways the grey market trades an IPO application before listing.
The Kostak rate for Anlon Healthcare IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not available for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Anlon Healthcare IPO
Anlon Healthcare Limited was incorporated in 2013. It is a chemical manufacturing company that makes high-purity pharmaceutical intermediates and active pharmaceutical ingredients.
These products are raw materials for medicines such as tablets, capsules, ointments and syrups. They are also used in nutraceuticals, personal care and animal health products.
The products are manufactured to pharmacopeia standards including IP, BP, EP, JP and USP. The company also offers custom manufacturing of complex chemicals.
The IPO was a fresh issue of Rs 121.03 crore. Rs 43.15 crore was planned for working capital and Rs 30.72 crore for expansion.
Frequently asked
What is the GMP of Anlon Healthcare IPO?
The current Grey Market Premium (GMP) of Anlon Healthcare IPO is ₹ 2.
What is the Kostak Price of Anlon Healthcare IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Anlon Healthcare IPO is not available.
What is the Subject to Sauda Price of Anlon Healthcare IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.
What was the actual listing price of Anlon Healthcare IPO?
Anlon Healthcare IPO listed on September 3, 2025 at ₹92, against the issue price of ₹91 — a gain of +1.1%.
How did the GMP of Anlon Healthcare IPO trend before listing?
The GMP of Anlon Healthcare IPO was falling in its final days before listing. The GMP peaked at ₹5 on 25 August 2025. View the day-wise table above for the complete GMP history.
Explore Anlon Healthcare IPO further
The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.
It has listed — go back to the fundamentals.
Category-wise demand from QIB, NII and retail investors, updated through the day.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
The grey market called it. Now check the fundamentals.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
